These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7588983)

  • 1. Appropriate fluid regimens to prevent bronchopulmonary dysplasia.
    Tammela OK
    Eur J Pediatr; 1995; 154(8 Suppl 3):S15-8. PubMed ID: 7588983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
    J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants.
    Van Marter LJ; Leviton A; Allred EN; Pagano M; Kuban KC
    J Pediatr; 1990 Jun; 116(6):942-9. PubMed ID: 2189976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of fluid restriction during the 1st month of life to the occurrence and severity of bronchopulmonary dysplasia in low birth weight infants: a 1-year radiological follow up.
    Tammela OK; Lanning FP; Koivisto ME
    Eur J Pediatr; 1992 May; 151(5):367-71. PubMed ID: 1396893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of fluid restriction during the 1st month of life to the occurrence and severity of bronchopulmonary dysplasia in low birth weight infants: a 1-year radiological follow up.
    Tammela OK; Lanning FP; Koivisto ME
    Eur J Pediatr; 1992 Apr; 151(4):295-9. PubMed ID: 1499583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants.
    Stephens BE; Gargus RA; Walden RV; Mance M; Nye J; McKinley L; Tucker R; Vohr BR
    J Perinatol; 2008 Feb; 28(2):123-8. PubMed ID: 18046337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid restriction for preventing bronchopulmonary dysplasia? Reduced fluid intake during the first weeks of life improves the outcome of low-birth-weight infants.
    Tammela OK; Koivisto ME
    Acta Paediatr; 1992 Mar; 81(3):207-12. PubMed ID: 1511192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid and electrolyte management of very low birth weight infants.
    Oh W
    Pediatr Neonatol; 2012 Dec; 53(6):329-33. PubMed ID: 23276435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive approach to the prevention of bronchopulmonary dysplasia.
    Kugelman A; Durand M
    Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
    Mourani PM; Sontag MK; Younoszai A; Miller JI; Kinsella JP; Baker CD; Poindexter BB; Ingram DA; Abman SH
    Am J Respir Crit Care Med; 2015 Jan; 191(1):87-95. PubMed ID: 25389562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of bronchopulmonary dysplasia.
    Chess PR; D'Angio CT; Pryhuber GS; Maniscalco WM
    Semin Perinatol; 2006 Aug; 30(4):171-8. PubMed ID: 16860156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In preterm infants, does fluid restriction, as opposed to liberal fluid prescription, reduce the risk of important morbidities and mortality?
    Abbas S; Keir AK
    J Paediatr Child Health; 2019 Jul; 55(7):860-866. PubMed ID: 31270874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchopulmonary dysplasia: clinical practices in five Portuguese neonatal intensive care units.
    Guimarães H; Rocha G; Vasconcellos G; Proença E; Carreira ML; Sossai MR; Morais B; Martins I; Rodrigues T; Severo M
    Rev Port Pneumol; 2010; 16(2):273-86. PubMed ID: 20437004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency, severity and risk factors for bronchopulmonary dysplasia among very low birth weight premature infants admitted in the NICU of the University Obstetrics and Gynecology Hospital, Sofia].
    Vakrilova L; Slancheva B; Hitrova S; Popivanova A; Emilova Z; Yarakova N
    Akush Ginekol (Sofiia); 2013; 52(1):21-9. PubMed ID: 23805457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or less than 28 weeks gestation.
    Malikiwi AI; Lee YM; Davies-Tuck M; Wong FY
    Early Hum Dev; 2019 Apr; 131():29-35. PubMed ID: 30825742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
    Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M;
    J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.